Atea Pharmaceuticals, Inc. Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Boston MA United States (2014)

Organization Overview

First Clinical Trial
2017
NCT03219957
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Atea Pharmaceuticals | Atea Pharmaceuticals, Inc.